Newsroom

SUMMIT, NJ—April 30, 2014 – Merck Animal Health today introduced Coccivac® Scheduler, an iPad® app, which will help poultry producers create best management practices protocols focused on minimizing the costly and persistent threat of coccidiosis. The most significant and common intestinal poultry disease, coccidiosis costs global poultry producers an estimated $300 million annually in production losses.1Working with […]

Read more

DE SOTO, Kan., April 29, 2014 – In recognition of his dedication to advancing technology and information sharing among bovine veterinarians, Roger Winter, D.V.M. has been awarded the Academy of Veterinary Consultants’ (AVC) 2014 Outstanding Service Award. An advocate of continuous learning and professional advancement, Dr. Winter has committed his time and talent to ensuring […]

Read more

SUMMIT, NEW JERSEY, August 28, 2014 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced its sponsorship of the 10th International Sea Lice Conference, being hosted for the first time in the U.S. The conference, “Sustainable Solutions in Sea Lice Management,” will take place August 31 through September […]

Read more

Summit, N.J., April 10, 2014 – Merck Animal Health today announced the availability of MILDVAC-Ma5®, a vaccine to control Massachusetts-type infectious bronchitis virus (IBV) – the most prevalent IBV serotype worldwide1 and one that costs the U.S. poultry industry millions of dollars in revenue loss each year.2 IBV targets not only the respiratory tract but […]

Read more

DE SOTO, Kan., April 10, 2014 – Five distinguished cattle veterinarians have been nominated and voting is underway for the 2014 Cattle Production Veterinarian Hall of Fame, which was created in 2011 to honor exceptional individuals who have made lasting contributions to the veterinary profession. This year’s outstanding nominees have played leading roles throughout their […]

Read more

SUMMIT, N.J., March 24, 2014 — Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved two additional indications for AQUAFLOR® (florfenicol*) Type A Medicated Article. The supplemental approval provides for an increase in the maximum daily dosage for […]

Read more

Awards $100,000 to Veterinary Students SUMMIT, N.J., March 20, 2014 – Merck Animal Health today announced the recipients of the Merck Animal Health Veterinary Student Scholarship Program, awarding $100,000 in scholarships to 20 veterinary students. Through a partnership with the American Veterinary Medical Foundation (AVMF), the program recognizes outstanding second and third year students who […]

Read more

First Insulin Pen for Dogs and Cats Makes Managing Diabetes More Convenient SUMMIT, NJ—March 19, 2014 – Merck Animal Health today announced that the U.S. Food and Drug Administration (FDA) has recently approved VetPen®, the first insulin pen for use in diabetic dogs and cats. For years, insulin pens have made managing diabetes more convenient […]

Read more

Eliminates More Than 99 Percent of Fleas: More Flea-Free Pets and Fewer Fleas in the Home SUMMIT, N.J., February 26, 2014 – Merck Animal Health today released the results of a head-to-head research study that showed ACTIVYL® (indoxacarb) was more effective than FRONTLINE® Plus (fipronil [s]-methoprene) in controlling flea populations on pets.1 ACTIVYL eliminated more than 99 […]

Read more

Only Intranasal Vaccine to Control Bacterial Pneumonia in Cattle DE SOTO, Kan. Feb. 4, 2014 – Merck Animal Health today introduced Once PMH® IN, the only intranasal vaccine to deliver dual bacterial pneumonia protection in healthy beef and dairy cattle, including calves as young as 1 week of age. Once PMH® IN aids in the control of […]

Read more